Barclays Maintains Overweight on CRH, Lowers Price Target to $110
Barclays analyst Adam Seiden maintains CRH (NYSE:CRH) with a Overweight and lowers the price target from $131 to $110.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga